Learn More
Apexbio Technology LLC NVP-BHG712 940310-85-0 200mg

Supplier: Apexbio Technology LLC A8683200
NVP-BHG712 (CAS 940310-85-0) is a selective small molecule inhibitor targeting the EphB4 receptor tyrosine kinase exhibiting an ED50 of 5 nM for EphB4 and reduced activity toward VEGFR2 (ED50 4200 nM) NVP-BHG712 demonstrates potent inhibition of EphB4 phosphorylation in cellular assays and shows weaker effects on EphB2 EphA2 EphB3 and EphA3 In cell-based models NVP-BHG712 suppresses proliferation and viability of synovial sarcoma cells and increases paclitaxel sensitivity in HEK293/ABCC10 cells In vivo it inhibits VEGF-induced angiogenesis and reduces tumor growth and metastasis in murine xenograft models This compound is a valuable probe for studying EphB4-mediated signaling in cancer and angiogenesis research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.